Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

How Artificial Intelligence Is Revolutionizing Emergency Medicine

From triage algorithms to digital twins, artificial intelligence is reshaping emergency care, delivering faster decisions, smarter workflows, and raising vital questions about trust, transparency, and regulation.

The Role of AI in Pathogen Detection and Epidemic Prediction

Artificial Intelligence in Cardiology

Artificial Intelligence and Life Science

Artificial Intelligence in Histopathology

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

Uncovering the Mystery of the Human Brain with Computational Neuroscience

What does ChatGPT mean for Healthcare?

Applying Deep Learning to Localization Microscopy

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

Managing the Explosion of Healthcare Data to Harness its Power

Deep-Learning in Radiology

See more featured articles »

Is Data at the Center of Healthcare for the Future?

Recent Developments in Health Technology

Artificial Intelligence and Deep Learning in Medicine

Machine Learning in Drug Development

The Pros and Cons of Healthcare Chatbots

Artificial Intelligence in CBT

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

The Medical Industries That Are Most Likely to Be Impacted by Ai

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

Ethical Considerations in AI-Driven Healthcare

Latest Artificial Intelligence News and Research

T cells drive vaccine effectiveness against porcine reproductive and respiratory syndrome virus

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the production of antibodies.

17 Nov 2025

FAU professor receives $746,998 to advance understanding of how the brain learns to see

Vision is one of the most fundamental senses, shaping how we perceive, navigate and interact with the world around us. Yet for more than 12 million Americans living with visual impairments, even small deficits can profoundly impact daily life, limiting independence and overall quality of life.

17 Nov 2025

Johns Hopkins study links mild pancreatic duct dilatation to higher cancer risk

Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030, according to the National Institutes of Health (NIH).

14 Nov 2025

MD Anderson launches historic $2.5 billion campaign to end cancer

The University of Texas MD Anderson Cancer Center today launches its historic $2.5 billion comprehensive philanthropic campaign, Only Possible Here, The Campaign to End Cancer.

14 Nov 2025

Analysis reveals overutilization of imaging in Bell's palsy

This study analyzes how imaging is used to diagnose and manage Bell's palsy, a condition that causes sudden weakness in the muscles on one side of the face, usually temporarily.

14 Nov 2025

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its collaboration with the California Institute of Technology (Caltech) on a newly awarded $2.8 million Discovery Stage Research (DISC0) grant from the California Institute for Regenerative Medicine (CIRM).

14 Nov 2025

Enhancing the cancer-immunity cycle through innovative vaccines

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat malignancies.

14 Nov 2025

UCSF study explores sentiment analysis for hepatorenal syndrome

Taking a page from market research tactics, UC San Francisco experts are studying whether artificial intelligence (AI) can improve diagnosis of a complex liver condition by using the clinical notes of multiple providers.

14 Nov 2025

Bruker announces advancements in immunopeptidomics, de novo PTM analysis, and proteoform profiling

international HUPO, Bruker Corporation today announced new machine learning additions to Bruker ProteoScape™ software for immunopeptidomics and PTM analysis.

From Bruker BioSpin - NMR, EPR and Imaging 14 Nov 2025

Study unites global neuroscientists to share brain data

Imagine if every neuroscientist in the world could suddenly speak the same language and share their discoveries instantly. Allen Institute researchers and engineers have now unlocked that potential and the vast discoveries it could lead to through the new Brain Knowledge Platform (BKP).

14 Nov 2025

Machine learning model boosts success of liver transplants from circulatory death donors

There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a match is found with a donor who dies after cardiac arrest following the removal of life support, the transplant must be canceled.

13 Nov 2025

Cellarity's AI model predicts drug-induced liver injury

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in Nature Communications, which describes a novel framework for the prediction and characterization of drug-induced liver injury (DILI), along with open-source posting of the model and validation data.

13 Nov 2025

APA urges safeguards for using AI in mental health

Emotional support is an increasingly common reason people turn to generative artificial intelligence chatbots and wellness applications, but these tools currently lack the scientific evidence and the necessary regulations to ensure users' safety, according to a new health advisory by the American Psychological Association.

13 Nov 2025

Empowering early detection of dementia with a dual approach involving AI and patient input

Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited time that primary care clinicians are able to spend with patients, the need to focus on the health problems which brought the patient to the clinic, as well as the stigma of Alzheimer's disease and dementia are major reasons for lack of recognition of the condition.

13 Nov 2025

Breakthroughs in theranostic nanomaterials for traumatic brain injury management

Traumatic brain injury (TBI) remains one of the most pressing public health challenges, leaving millions with lasting disabilities each year.

12 Nov 2025

Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an improved framework for evaluating benchmark metric calibration in virtual cell models. U

From Shift Bioscience 11 Nov 2025